UK scientists have identified markers associated with rare blood clots linked with the Oxford/AstraZeneca COVID-19 vaccine – and have issued guidance to doctors to help treat it effectively and increase survival chances.
New medical guidance will help identify and treat rare blood clots linked to AstraZeneca jab